Skip to main content
Smart Investors Daily
Bioceres Crop Solutions Corp. logo

NASDAQ · BIOX

Bioceres Crop Solutions Corp.

Basic Materials · Agricultural Inputs

$0.44

Down-$0.01 (-2.00%)

Updated Aug 22, 2026, 3:34 PM

SID Score

3.8/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
100.14M
P/E ratio
-1.96
Dividend yield
0.00%
52-week range
$0.30 – $0.70
Volume
824.98K
Avg. volume
831.92K

Price performance

BIOX price history

1M range · 0 trading sessions · Daily adjusted prices

BIOX does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest BIOX news

The latest Smart Investors Daily articles mentioning BIOX.

BIOX research

Overview

Company profile and research snapshot.

Company profile

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
$4.17
Implied upside
Analysts
BIOX recent ratings
DateFirmRatingTarget
Jan 2, 2026Canaccord GenuityHold
Nov 14, 2025Canaccord GenuityHold
Sep 10, 2025Lake StreetBuy
Sep 10, 2025Canaccord GenuityHold
Jul 15, 2025OppenheimerOutperform
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Dec 3, 2025

Why Analysts Say Bioceres’ Story Is Shifting Amid Liquidity Fears Yet Long Term Promise

Bioceres Crop Solutions has just seen its fair value estimate cut from $3.63 to $2.25 per share, even as analysts nudge their revenue growth outlook slightly higher and trim the discount rate applied to the stock. This recalibration reflects a market narrative that is growing more cautious on near term liquidity and execution risk in Argentina, yet still credits the company with solid long term earnings potential from its next generation product pipeline. Stay tuned to learn how you can track...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.